FACTANKER · measured, cited, anchored official records connected

SONOMA PHARMACEUTICALS, INC. — Revenue by Fiscal Year

16 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/72ce4765-36b0-467e-968e-5349d7f3f1d4/serie/revenue

Fiscal yearRevenuePeriodEvidence
FY 2025$19.5M2025-04-01 – 2026-03-31evidence 0001683168-26-004871
FY 2024$14.3M2024-04-01 – 2025-03-31evidence 0001683168-25-004546
FY 2023$12.7M2023-04-01 – 2024-03-31evidence 0001683168-24-004275
FY 2022$13.3M2022-04-01 – 2023-03-31evidence 0001683168-23-004323
FY 2021$12.6M2021-04-01 – 2022-03-31evidence 0001683168-22-004940
FY 2020$18.6M2020-04-01 – 2021-03-31evidence 0001683168-21-002977
FY 2019$17.9M2019-04-01 – 2020-03-31evidence 0001683168-21-002977
FY 2018$19.0M2018-04-01 – 2019-03-31evidence 0001683168-20-002234
FY 2017$16.7M2017-04-01 – 2018-03-31evidence 0001683168-18-001786
FY 2016$12.8M2016-04-01 – 2017-03-31evidence 0001683168-18-001786
FY 2015$8.1M2015-04-01 – 2016-03-31evidence 0001683168-17-001670
FY 2014$9.9M2014-04-01 – 2015-03-31evidence 0001019687-15-002432
FY 2013$7.2M2013-04-01 – 2014-03-31evidence 0001019687-15-002432
FY 2012$12.9M2012-04-01 – 2013-03-31evidence 0001019687-13-002453
FY 2011$11.5M2011-04-01 – 2012-03-31evidence 0001019687-13-002453
FY 2010$8.8M2010-04-01 – 2011-03-31evidence 0001019687-12-002202
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

SONOMA PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income